Antiviral Drugs Market Size, Share, Growth, and Industry Analysis, By Type (Reverse Transcriptase Inhibitors, Protease Inhibitors, Fusion Inhibitors, Immune System Modulators), By Application (Hepatitis Therapeutics, HIV/AIDS Therapeutics, Herpes Therapeutics, Influenza Therapeutics), Regional Insights and Forecast From 2026 To 2035

Detailed TOC of Global and United States Antiviral Drugs Market Report & Forecast 2022-2035

1 Study Coverage
1.1 Antiviral Drugs Product Introduction
1.2 Global Antiviral Drugs Outlook 2017 VS 2022 VS 2035
1.2.1 Global Antiviral Drugs Sales in US$ Million for the Year 2017-2035
1.2.2 Global Antiviral Drugs Sales in Volume for the Year 2017-2035
1.3 United States Antiviral Drugs Outlook 2017 VS 2022 VS 2035
1.3.1 United States Antiviral Drugs Sales in US$ Million for the Year 2017-2035
1.3.2 United States Antiviral Drugs Sales in Volume for the Year 2017-2035
1.4 Antiviral Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2035
1.4.1 The Market Share of United States Antiviral Drugs in Global, 2017 VS 2022 VS 2035
1.4.2 The Growth Rate of Antiviral Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2035
1.5 Antiviral Drugs Market Dynamics
1.5.1 Antiviral Drugs Industry Trends
1.5.2 Antiviral Drugs Market Drivers
1.5.3 Antiviral Drugs Market Challenges
1.5.4 Antiviral Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Antiviral Drugs Market Segment by Type
2.1.1 Reverse Transcriptase Inhibitors
2.1.2 Protease Inhibitors
2.1.3 Fusion Inhibitors
2.1.4 Immune System Modulators
2.2 Global Antiviral Drugs Market Size by Type
2.2.1 Global Antiviral Drugs Sales in Value, by Type (2017, 2022 & 2035)
2.2.2 Global Antiviral Drugs Sales in Volume, by Type (2017, 2022 & 2035)
2.2.3 Global Antiviral Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2035)
2.3 United States Antiviral Drugs Market Size by Type
2.3.1 United States Antiviral Drugs Sales in Value, by Type (2017, 2022 & 2035)
2.3.2 United States Antiviral Drugs Sales in Volume, by Type (2017, 2022 & 2035)
2.3.3 United States Antiviral Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2035)
3 Market by Application
3.1 Antiviral Drugs Market Segment by Application
3.1.1 Hepatitis Therapeutics
3.1.2 HIV/AIDS Therapeutics
3.1.3 Herpes Therapeutics
3.1.4 Influenza Therapeutics
3.2 Global Antiviral Drugs Market Size by Application
3.2.1 Global Antiviral Drugs Sales in Value, by Application (2017, 2022 & 2035)
3.2.2 Global Antiviral Drugs Sales in Volume, by Application (2017, 2022 & 2035)
3.3.3 Global Antiviral Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2035)
3.3 United States Antiviral Drugs Market Size by Application
3.3.1 United States Antiviral Drugs Sales in Value, by Application (2017, 2022 & 2035)
3.3.2 United States Antiviral Drugs Sales in Volume, by Application (2017, 2022 & 2035)
3.3.3 United States Antiviral Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2035)
4 Global Antiviral Drugs Competitor Landscape by Company
4.1 Global Antiviral Drugs Market Size by Company
4.1.1 Top Global Antiviral Drugs Manufacturers Ranked by Revenue (2021)
4.1.2 Global Antiviral Drugs Revenue by Manufacturer (2017-2022)
4.1.3 Global Antiviral Drugs Sales by Manufacturer (2017-2022)
4.1.4 Global Antiviral Drugs Price by Manufacturer (2017-2022)
4.2 Global Antiviral Drugs Concentration Ratio (CR)
4.2.1 Antiviral Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Antiviral Drugs in 2021
4.2.3 Global Antiviral Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Antiviral Drugs Manufacturing Base Distribution, Product Type
4.3.1 Global Antiviral Drugs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Antiviral Drugs Product Type
4.3.3 Date of International Manufacturers Enter into Antiviral Drugs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Antiviral Drugs Market Size by Company
4.5.1 Top Antiviral Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Antiviral Drugs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Antiviral Drugs Sales by Players (2020, 2021 & 2022)
5 Global Antiviral Drugs Market Size by Region
5.1 Global Antiviral Drugs Market Size by Region: 2017 VS 2022 VS 2035
5.2 Global Antiviral Drugs Market Size in Volume by Region (2017-2035)
5.2.1 Global Antiviral Drugs Sales in Volume by Region: 2017-2022
5.2.2 Global Antiviral Drugs Sales in Volume Forecast by Region (2023-2035)
5.3 Global Antiviral Drugs Market Size in Value by Region (2017-2035)
5.3.1 Global Antiviral Drugs Sales in Value by Region: 2017-2022
5.3.2 Global Antiviral Drugs Sales in Value by Region: 2023-2035
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Antiviral Drugs Market Size YoY Growth 2017-2035
6.1.2 North America Antiviral Drugs Market Facts & Figures by Country (2017, 2022 & 2035)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Antiviral Drugs Market Size YoY Growth 2017-2035
6.2.2 Asia-Pacific Antiviral Drugs Market Facts & Figures by Region (2017, 2022 & 2035)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Antiviral Drugs Market Size YoY Growth 2017-2035
6.3.2 Europe Antiviral Drugs Market Facts & Figures by Country (2017, 2022 & 2035)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Antiviral Drugs Market Size YoY Growth 2017-2035
6.4.2 Latin America Antiviral Drugs Market Facts & Figures by Country (2017, 2022 & 2035)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Antiviral Drugs Market Size YoY Growth 2017-2035
6.5.2 Middle East and Africa Antiviral Drugs Market Facts & Figures by Country (2017, 2022 & 2035)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Roche
7.1.1 Roche Corporation Information
7.1.2 Roche Description and Business Overview
7.1.3 Roche Antiviral Drugs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Roche Antiviral Drugs Products Offered
7.1.5 Roche Recent Development
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Corporation Information
7.2.2 Johnson & Johnson Description and Business Overview
7.2.3 Johnson & Johnson Antiviral Drugs Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Johnson & Johnson Antiviral Drugs Products Offered
7.2.5 Johnson & Johnson Recent Development
7.3 Merck
7.3.1 Merck Corporation Information
7.3.2 Merck Description and Business Overview
7.3.3 Merck Antiviral Drugs Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Merck Antiviral Drugs Products Offered
7.3.5 Merck Recent Development
7.4 Novartis
7.4.1 Novartis Corporation Information
7.4.2 Novartis Description and Business Overview
7.4.3 Novartis Antiviral Drugs Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Novartis Antiviral Drugs Products Offered
7.4.5 Novartis Recent Development
7.5 Bristol-Myers Squibb
7.5.1 Bristol-Myers Squibb Corporation Information
7.5.2 Bristol-Myers Squibb Description and Business Overview
7.5.3 Bristol-Myers Squibb Antiviral Drugs Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Bristol-Myers Squibb Antiviral Drugs Products Offered
7.5.5 Bristol-Myers Squibb Recent Development
7.6 Gilead Sciences
7.6.1 Gilead Sciences Corporation Information
7.6.2 Gilead Sciences Description and Business Overview
7.6.3 Gilead Sciences Antiviral Drugs Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Gilead Sciences Antiviral Drugs Products Offered
7.6.5 Gilead Sciences Recent Development
7.7 GlaxoSmithKline
7.7.1 GlaxoSmithKline Corporation Information
7.7.2 GlaxoSmithKline Description and Business Overview
7.7.3 GlaxoSmithKline Antiviral Drugs Sales, Revenue and Gross Margin (2017-2022)
7.7.4 GlaxoSmithKline Antiviral Drugs Products Offered
7.7.5 GlaxoSmithKline Recent Development
7.8 AbbVie
7.8.1 AbbVie Corporation Information
7.8.2 AbbVie Description and Business Overview
7.8.3 AbbVie Antiviral Drugs Sales, Revenue and Gross Margin (2017-2022)
7.8.4 AbbVie Antiviral Drugs Products Offered
7.8.5 AbbVie Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Antiviral Drugs Industry Chain Analysis
8.2 Antiviral Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Antiviral Drugs Distributors
8.3 Antiviral Drugs Production Mode & Process
8.4 Antiviral Drugs Sales and Marketing
8.4.1 Antiviral Drugs Sales Channels
8.4.2 Antiviral Drugs Distributors
8.5 Antiviral Drugs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer